- Type / Class
- Equity / COM
- Shares outstanding
- 258,506,508
- Total 13F shares
- 3,396,258
- Share change
- -338
- Total reported value
- $46,661,907
- Price per share
- $13.74
- Number of holders
- 42
- Value change
- -$4,880
- Number of sells
- 1
Quarterly Holders Quick Answers
What is CUSIP 29664W105?
CUSIP 29664W105 identifies ESPR - Esperion Therapeutics, Inc. - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29664W105:
Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,377
|
$26,000 | — | 30 Sep 2013 |
Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q4 2013
As of 31 Dec 2013,
Esperion Therapeutics, Inc. - COM (ESPR) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,396,258 shares.
The largest 10 holders included
Pentwater Capital Management LP, Polar Capital LLP, WASATCH ADVISORS INC, BlackRock Fund Advisors, Iguana Healthcare Management, LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., FMR LLC, Alyeska Investment Group, L.P., and NORTHERN TRUST CORP.
This page lists
42
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2013 vs Q3 2013 Across Filers
Q3 2013 holders
1
Q4 2013 holders
42
Holder diff
41
| Investor | Q3 2013 Shares | Q4 2013 Shares | Share Diff | Share Chg % | Q3 2013 Value $ | Q4 2013 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.